Long Term Safety Study of NVA237 vs QAB149 in COPD Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

511

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

NVA237

NVA237 will be supplied in capsule form in blister packs for use in the Novartis Concept 1 SDDPI

DRUG

Long-acting beta 2-agonist (LABA)

QAB149 and matching placebo will be supplied in capsule form in blister packs for use in the Novartis Concept 1 SDDPI

DRUG

Placebo

Placebo to match QAB149

Trial Locations (61)

19140

Novartis Investigative Site, Philadelphia

20110

Novartis Investigative Site, Manassas

22015

Novartis Investigative Site, Burke

22401

Novartis Investigative Site, Fredericksburg

23225

Novartis Investigative Site, Richmond

23229

Novartis Investigative Site, Richmond

28463

Novartis Investigative Site, Tabor City

28467

Novartis Investigative Site, Calabash

29204

Novartis Investigative Site, Columbia

29412

Novartis Investigative Site, Charleston

29582

Novartis Investigative Site, North Myrtle Beach

29605

Novartis Investigative Site, Greenville

29651

Novartis Investigative Site, Greer

32503

Novartis Investigative Site, Pensacola

33016

Novartis Investigative Site, Hialeah

33165

Novartis Investigative Site, Miami

33172

Novartis Investigative Site, Miami

33175

Novartis Investigative Site, Miami

33334

Novartis Investigative Site, Oakland Park

33765

Novartis Investigative Site, Clearwater

36547

Novartis Investigative Site, Gulf Shores

36608

Novartis Investigative Site, Mobile

41042

Novartis Investigative Site, Florence

42431

Novartis Investigative Site, Madisonville

43215

Novartis Investigative Site, Columbus

43235

Novartis Investigative Site, Columbus

43302

Novartis Investigative Site, Marion

43701

Novartis Investigative Site, Zanesville

47630

Novartis Investigative Site, Newburgh

53575

Novartis Investigative Site, Oregon

55402

Novartis Investigative Site, Minneapolis

55407

Novartis Investigative Site, Minneapolis

55432

Novartis Investigative Site, Fridley

55435

Novartis Investigative Site, Edina

66606

Novartis Investigative Site, Topeka

68025

Novartis Investigative Site, Fremont

68134

Novartis Investigative Site, Omaha

70119

Novartis Investigative Site, New Orleans

70570

Novartis Investigative Site, Opelousas

77043

Novartis Investigative Site, Houston

77081

Novartis Investigative Site, Houston

77339

Novartis Investigative Site, Kingwood

78006

Novartis Investigative Site, Boerne

78229

Novartis Investigative Site, San Antonio

79902

Novartis Investigative Site, El Paso

80033

Novartis Investigative Site, Wheat Ridge

80528

Novartis Investigative Site, Fort Collins

83814

Novartis Investigative Site, Couer D'Alene

85712

Novartis Investigative Site, Tucson

89014

Novartis Investigative Site, Henderson

89119

Novartis Investigative Site, Las Vegas

92506

Novartis Investigative Site, Riverside

06033

Novartis Investigative Site, Glastonbury

06902

Novartis Investigative Site, Stamford

06708

Novartis Investigative Site, Waterbury

04005

Novartis Investigative Site, Biddeford

01608

Novartis Investigative Site, Worchester

03756

Novartis Investigative Site, Lebanon

97404-3233

Novartis Investigative Site, Eugene

02886

Novartis Investigative Site, Warwick

05009

Novartis Investigative Site, White River Junction

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY